CD274 and head and neck squamous cell carcinoma: In the Keynote048 clinical trial [2], PDL1 expression was not a prognostic or a predictive factor in patients enrolled in the control arms treated with the Extreme regimen (cisplatin + 5-fluorouracil + cetuximab); thus, the prognostic role of PD-L1 in HNSCC is still under debate.